PLUS1
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time Level 1 for London Stock Exchange + FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +16.8 | +1.13% | 1,498.6 | 1,504.2 | 1,480.2 | 1,490.4 | 1,481.8 | 11:35:18 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1,499.2 | 1,500 | 0.8 | 0.05% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,750 | 6,851,110 | 1,496.1779p | 102.5Mp | - | 1,236.40 - 1,648.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:46:54 | O | 283,716 | 1,498.60p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| 74.4Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | -p | 0.00% | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/15/2019 | 12:15 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 1/15/2019 | 11:09 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 1/15/2019 | 10:01 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 1/15/2019 | 09:59 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 1/15/2019 | 09:56 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 1/15/2019 | 09:47 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 1/15/2019 | 07:48 | Alliance News |  GlaxoSmithKline Extends Expiration Date For Tesaro Tender.. |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 12/19/2018 | 04:42 | - | Yep 39 now with 5% divvy I don''t |
| 12/19/2018 | 04:18 | - | GSK, PFE form consumer-health JV: #msg-145552190. |
| 12/19/2018 | 04:10 | - | I agree with your theory completely make total sense. |
| 6/13/2018 | 03:33 | - | Novartis'' Entresto is nothing more than an attempt |
| 3/04/2018 | 09:40 | - | Buy anything below 36 not much down side risk. |
| 2/08/2018 | 10:04 | - | Copy of Presentation: |
| 2/07/2018 | 07:50 | - | GSK 4Q17 CC slides: |
| 10/23/2017 | 05:30 | - | https://seekingalpha.com/article/4115400-glaxosmithkline-lands-big-win-shingles- |
| 9/13/2017 | 07:32 | - | [b]Mymetics to Present New Preclinical Data on Thermostable |
| 8/11/2017 | 05:08 | - | Breakthrough in vaccine delivery will disrupt the vaccine |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 1,537 | 1,549 | 1,467.2 | 1,500.0425 | 6M | 10M | 8M | -38.4 | -2.50% |
| 1 Month | 1,501.2 | 1,556.2 | 1,463.4 | 1,508.9333 | 3M | 23M | 8M | -2.6 | -0.17% |
| 3 Months | 1,522 | 1,648.8 | 1,408.8 | 1,515.7660 | 3M | 32M | 11M | -23.4 | -1.54% |
| 6 Months | 1,561.2 | 1,648.8 | 1,408.8 | 1,526.6975 | 3M | 32M | 10M | -62.6 | -4.01% |
| 1 Year | 1,351.4 | 1,648.8 | 1,236.4 | 1,474.8566 | 3M | 32M | 9M | 147.2 | 10.89% |
| 3 Years | 1,389.5 | 1,735.5 | 1,236.4 | 1,507.6555 | 736k | 34M | 9M | 109.1 | 7.85% |
| 5 Years | 1,639.5 | 1,735.5 | 1,227.5 | 1,488.3292 | 371k | 37M | 9M | -140.9 | -8.59% |
